Bullishcharts

$ABUS Arbutus Pharma 25% upside

Long
NASDAQ:ABUS   Arbutus Biopharma Corporation

Looks primed and ready for bull-break
20ma break is the key

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.